E

EZZ Life Science Holdings Ltd
ASX:EZZ

Watchlist Manager
EZZ Life Science Holdings Ltd
ASX:EZZ
Watchlist
Price: 2.23 AUD -7.85%
Market Cap: 105.2m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

EZZ Price Targets Summary
EZZ Life Science Holdings Ltd

There are no price targets for EZZ.
EZZ Lowest Forecast
Wall Street Target
Not Available
EZZ Average Forecast
Wall Street Target
Not Available
EZZ Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
EZZ Life Science Holdings Ltd Competitors:
Price Targets
207940
Samsung Biologics Co Ltd
36% Upside
VIMTALABS
Vimta Labs Ltd
38% Downside
E
EVT
Evotec SE
45% Upside
300759
Pharmaron Beijing Co Ltd
24% Upside
207940
Samsung Biologics Co Ltd
36% Upside
VIMTALABS
Vimta Labs Ltd
38% Downside
E
EVT
Evotec SE
45% Upside
300759
Pharmaron Beijing Co Ltd
24% Upside
BRKR
Bruker Corp
29% Upside
SYNGENE
Syngene International Ltd
14% Upside
MTD
Mettler-Toledo International Inc
6% Upside
G
688046
GemPharmatech Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
EZZ Life Science Holdings Ltd

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's revenue is 43%. The projected CAGR for the next 3 years is 19%.

43%
Past Growth
19%
Estimated Growth
Estimates Accuracy
28%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
EZZ Life Science Holdings Ltd

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's operating income is 54%. The projected CAGR for the next 4 years is 13%.

54%
Past Growth
13%
Estimated Growth
Estimates Accuracy
92%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
EZZ Life Science Holdings Ltd

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's net income is 53%. The projected CAGR for the next 3 years is 23%.

53%
Past Growth
23%
Estimated Growth
Estimates Accuracy
34%
Average Beat
What are analyst estimates?

See Also

Summary
EZZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
EZZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EZZ stock valuation using valuation multiples.
Wall Street Estimates
EZZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EZZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EZZ's stock price target?
Not Available

EZZ doesn't have any price targets made by Wall Street professionals.

What is EZZ Life Science Holdings Ltd's Revenue forecast?
Projected CAGR
19%

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's revenue is 43%. The projected CAGR for the next 3 years is 19%.

What is EZZ Life Science Holdings Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's operating income is 54%. The projected CAGR for the next 4 years is 13%.

What is EZZ Life Science Holdings Ltd's Net Income forecast?
Projected CAGR
23%

For the last 5 years the compound annual growth rate for EZZ Life Science Holdings Ltd's net income is 53%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.